Insider Trades
Common-stock transactions that officers, directors and 10% owners of healthcare companies report to the SEC on Form 4, from 2006 to today, newest first.
Insider filings are public records and are not a recommendation.
Results
25+ transactions, newest first
| Date | Insider | Relationship | Company | Transaction | Shares | Price | Value | Owned after | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 1,921 | $4.56 | $8,759.76 | 2,803,446Direct | Form 4 filed 18 Sep 2026, on sec.gov (opens in a new tab)Filed 18 Sep 2026 | |
| OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 3,170 | $4.64 | $14,708.80 | 275,897Direct | Form 4 filed 17 Sep 2026, on sec.gov (opens in a new tab)Filed 17 Sep 2026 | |
| Soares Karen | Chief Legal Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 6,846 | $4.78 | $32,723.88 | 1,607,371Direct | Form 4 filed 15 Sep 2026, on sec.gov (opens in a new tab)Filed 15 Sep 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 9,273 | $4.78 | $44,324.94 | 2,805,367Direct | Form 4 filed 15 Sep 2026, on sec.gov (opens in a new tab)Filed 15 Sep 2026 | |
| Wai Conrad | CEO, Counterpart Health | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 300,000 | $4.72 | $1,416,000 | 1,170,056Indirect, By Trust. | Form 4 filed 16 Sep 2026, on sec.gov (opens in a new tab)Filed 16 Sep 2026 | |
| OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 20,000 | $5.16 | $103,200 | 279,067Direct | Form 4 filed 14 Sep 2026, on sec.gov (opens in a new tab)Filed 14 Sep 2026 | |
| THORNTON JOSEPH CLAY | Interim CFO | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 17,775 | $4.39 | $78,032.25 | 1,249,526Direct | Form 4 filed 17 Aug 2026, on sec.gov (opens in a new tab)Filed 17 Aug 2026 | |
| Soares Karen | Chief Legal Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | OtherA · Grant or award from the company | 108,695 | $0.00 | $0 | 1,614,217Direct | Form 4 filed 13 Aug 2026, on sec.gov (opens in a new tab)Filed 13 Aug 2026 | |
| THORNTON JOSEPH CLAY | Interim CFO | CLOVER HEALTH INVESTMENTS, CORP.CLOV | OtherA · Grant or award from the company | 54,347 | $0.00 | $0 | 1,267,301Direct | Form 4 filed 13 Aug 2026, on sec.gov (opens in a new tab)Filed 13 Aug 2026 | |
| Toy Andrew | Director, Chief Executive Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 87,798 | $4.65 | $408,260.70 | 9,459,316Direct | Form 4 filed 10 Aug 2026, on sec.gov (opens in a new tab)Filed 10 Aug 2026 | |
| Soares Karen | Chief Legal Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 51,700 | $4.51 | $233,167 | 1,505,522Direct | Form 4 filed 20 Jul 2026, on sec.gov (opens in a new tab)Filed 20 Jul 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 4,839 | $4.53 | $21,920.67 | 2,814,640Direct | Form 4 filed 17 Jul 2026, on sec.gov (opens in a new tab)Filed 17 Jul 2026 | |
| Toy Andrew | Director, Chief Executive Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 62,711 | $4.67 | $292,860.37 | 9,547,114Direct | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 13,119 | $4.67 | $61,265.73 | 2,819,479Direct | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Wai Conrad | CEO, Counterpart Health | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 24,215 | $4.67 | $113,084.05 | 1,145,699Direct | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Soares Karen | Chief Legal Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 10,519 | $4.67 | $49,123.73 | 1,557,222Direct | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| THORNTON JOSEPH CLAY | Interim CFO | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 4,630 | $4.67 | $21,622.10 | 1,212,954Direct | Form 4 filed 16 Jul 2026, on sec.gov (opens in a new tab)Filed 16 Jul 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 2,384 | $4.68 | $11,157.12 | 2,832,598Direct | Form 4 filed 9 Jul 2026, on sec.gov (opens in a new tab)Filed 9 Jul 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 6,229 | $5.26 | $32,764.54 | 2,834,982Direct | Form 4 filed 6 Jul 2026, on sec.gov (opens in a new tab)Filed 6 Jul 2026 | |
| Toy Andrew | Director, Chief Executive Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 313,476 | $5.32 | $1,667,692.32 | 9,609,825Direct | Form 4 filed 1 Jul 2026, on sec.gov (opens in a new tab)Filed 1 Jul 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 2,360 | $4.78 | $11,280.80 | 2,841,211Direct | Form 4 filed 18 Jun 2026, on sec.gov (opens in a new tab)Filed 18 Jun 2026 | |
| OLDAKOWSKI JOSEPH FRANK | VP OF FINANCE AND CONTROLLER | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 12,102 | $4.86 | $58,815.72 | 299,067Direct | Form 4 filed 17 Jun 2026, on sec.gov (opens in a new tab)Filed 17 Jun 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 6,350 | $4.61 | $29,273.50 | 2,843,571Direct | Form 4 filed 16 Jun 2026, on sec.gov (opens in a new tab)Filed 16 Jun 2026 | |
| Soares Karen | Chief Legal Officer | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 4,681 | $4.61 | $21,579.41 | 1,567,741Direct | Form 4 filed 16 Jun 2026, on sec.gov (opens in a new tab)Filed 16 Jun 2026 | |
| Reynoso Jamie L. | CEO, Medicare Advantage | CLOVER HEALTH INVESTMENTS, CORP.CLOV | SellS · Open-market or private sale | 7,289 | $4.91 | $35,788.99 | 2,849,921Direct | Form 4 filed 11 Jun 2026, on sec.gov (opens in a new tab)Filed 11 Jun 2026 |
Source: SEC EDGAR Form 4 filings and the SEC Insider Transactions Data Sets (2006 onward). Each row links to its Form 4 filing. Values are shares times the reported price. Nothing here is investment advice.